Resolute Wealth Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Buy
1,636
+40
+3% +$40.6K 0.65% 29
2025
Q4
$1.72M Buy
1,596
+131
+9% +$125K 0.75% 30
2025
Q3
$1.12M Buy
1,465
+100
+7% +$74.4K 0.51% 34
2025
Q2
$1.06M Buy
1,365
+19
+1% +$14.8K 0.57% 30
2025
Q1
$1.11M Buy
1,346
+307
+30% +$255K 0.62% 31
2024
Q4
$802K Sell
1,039
-25
-2% -$20.7K 0.41% 37
2024
Q3
$943K Buy
1,064
+6
+0.6% +$5.39K 0.49% 33
2024
Q2
$958K Buy
1,058
+21
+2% +$16.8K 0.55% 30
2024
Q1
$806K Buy
1,037
+313
+43% +$223K 0.49% 35
2023
Q4
$422K Buy
724
+47
+7% +$27.4K 0.29% 54
2023
Q3
$364K Buy
677
+51
+8% +$26.3K 0.27% 57
2023
Q2
$293K Buy
+626
New +$263K 0.23% 66

Other funds holding LLY

Resolute Wealth Strategies's LLY Position: Q1 2026 in Review

Resolute Wealth Strategies increased its Eli Lilly (LLY) stake by 2.5% in Q1 2026, buying an estimated $40.6K and bringing the position to 1,636 shares worth $1.51M. The position accounts for 0.65% of the portfolio, ranked #29.

Resolute Wealth Strategies first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.72M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Resolute Wealth Strategies held 1,636 shares of Eli Lilly worth $1.51M as of Q1 2026.
  • Resolute Wealth Strategies bought 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
  • Eli Lilly made up 0.65% of Resolute Wealth Strategies's portfolio in Q1 2026, its #29 holding.
  • Resolute Wealth Strategies first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Resolute Wealth Strategies's Eli Lilly position peaked at $1.72M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Resolute Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.